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The Hampshire-Berkshire focus of L120Q anticoagulant resistance in the Norway rat (Rattus 1 
norvegicus) and field trials of bromadiolone, difenacoum and brodifacoum 2 
Alan P. Buckle,* Clare R. Jones, David J. Rymer,† Emily E. Coan§ and Colin V. Prescott 3 
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Abstract 5 
Anticoagulant resistance has been present in Norway rats (Rattus norvegicus) in Hampshire and 6 
Berkshire for forty years.  All first-generation anticoagulants and two of the second generation, 7 
bromadiolone and difenacoum, are resisted by rats carrying the L120Q single nucleotide 8 
polymorphism (SNP).  A regulatory restriction on the use of resistance-breakers brodifacoum, 9 
difethialone and flocoumafen in the UK effectively prevented their use against Norway rats for more 10 
than 30 years.  During this time, L120Q spread from original localised foci eventually to cover most 11 
of central-southern England; with other more dispersed foci elsewhere in the UK.  We summarise 12 
research on L120Q Norway rats and the field performance of anticoagulant baits against them.  13 
Bromadiolone (50 ppm), difenacoum (50 ppm) and brodifacoum (23 ppm) baits were each applied 14 
on two farmsteads where it had been established that Norway rats carried the L120Q SNP.  15 
Preliminary DNA resistance tests conducted at the farms found only one of 107 rats to be 16 
susceptible and 86.9% to be homozygous resistant.  The bromadiolone and difenacoum applications 17 
were either partially or wholly ineffective; brodifacoum treatments were fully effective.  Quantities 18 
of active substances used varied between farms and substances; but more bromadiolone and 19 
difenacoum baits were applied than brodifacoum baits during the treatments.  Results confirm the 20 
high incidence of resistance and support advice that bromadiolone and difenacoum should not be 21 
used against the L120Q SNP.  Prolonged use of resisted anticoagulants has resulted in a high 22 
prevalence of homozygosity and resistance spread.  Failed treatments result in prolonged feeding on 23 
anticoagulant bait and leave Norway rats alive carrying, presumably, high residues.  It remains to be 24 
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seen whether the use of now-permitted effective substances, and the introduction of a rodenticide 25 
stewardship regime, will curtail the spread of resistance and reduce anticoagulant residues in 26 
wildlife. 27 
KEY WORDS:  Anticoagulant resistance, Rattus norvegicus, second-generation anticoagulant 28 
rodenticide, L120Q, rodent control, non-target wildlife 29 
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1 INTRODUCTION 34 
The Norway rat (Rattus norvegicus) anticoagulant resistance focus in central southern England was 35 
first identified in 1969 (Greaves and Rennison, 1973) and came to be known as Hampshire 36 
difenacoum resistance (Greaves and Cullen-Ayres, 1988).  The focus was then considered to be 37 
‘relatively inconsequential’ but was recognised probably to be caused by a ‘different genotype’ to 38 
those found in the better-known Scottish, Welsh and Kent foci.  Fifty years later this focus has 39 
become one of the most extensive and severe anticoagulant resistance phenomena found anywhere 40 
in the world, due to the presence of the L120Q (leucine120glutamine) single nucleotide 41 
polymorphism (SNP) (Pelz and Prescott, 2015; Boitet et al., 2018).  Presently, the focus covers almost 42 
all of central-southern England, and L120Q rats are increasingly found more widely across the UK 43 
(Jones et al., 2019) 44 
Since their discovery, resistant rats from this part of the UK have been studied extensively, both in 45 
the laboratory and field, in attempts to resolve questions about the genetic nature of this resistance, 46 
the efficacy of anticoagulant rodenticides and behavioural traits that appear to co-exist with it.  All 47 
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of these questions remain only partially answered.  A laboratory feeding test for the identification of 48 
resistance to difenacoum was developed as a precautionary measure on the assumption that 49 
resistance to this, then, newly-introduced substance was likely to emerge among Norway rats 50 
sooner or later (Redfern and Gill, 1978).  This was prescient because the failure of difenacoum to 51 
control Norway rats on farms on the north Hampshire-Berkshire border was soon reported.  Rats 52 
taken from this area, and tested using the new resistance feeding test, were confirmed to be 53 
difenacoum-resistant, one female survived the consumption of 123.9 g of difenacoum bait (37.3 54 
mg.kg-1 of the active substance) (Redfern and Gill, 1978). 55 
Two further studies were conducted; one to identify the geographical extent of the new resistance 56 
focus and another to test the efficacy of three newly-developed anticoagulants within it.  The focus 57 
was found to be mainly within the boundaries of lines joining the Berkshire and Hampshire 58 
conurbations of Reading, Newbury, Andover, Winchester and Alton (Greaves et al., 1982a).  Field 59 
trials showed that, while bait containing 50 ppm difenacoum was largely ineffective within the focus, 60 
the efficacy of 50 ppm bromadiolone was also substantially impaired (Greaves et al., 1982b).  Only 61 
20 ppm brodifacoum baits were fully effective but control operations using this active substance 62 
took longer than normal, suggesting an albeit lesser degree of resistance. 63 
The results of these early studies were relatively unequivocal until resistance factors were derived 64 
from feeding tests for Norway rats from the ‘Hampshire’ focus as follows: difenacoum 3.9 (males) 65 
and 2.7 (females), bromadiolone 1.5 (males) and 2.9 (females), brodifacoum 2.0 (males and females) 66 
(Greaves and Cullen-Ayres, 1988).  Resistance factors were somewhat higher for a laboratory-bred 67 
‘selected line’ created by crossing and back-crossing to select for anticoagulant resistance.  However, 68 
resistance factors of this magnitude would not normally be expected to result in the degree of 69 
practical treatment failure observed (Greaves et al., 1982b), and factors of a similar magnitude for 70 
the same compounds were reported in other foci, such as Scotland and Wales, but without any 71 
similar diminution of practical treatment efficacy (Greaves and Cullen-Ayres, 1988). 72 
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Several explanations are conceivable for these observations but none is wholly convincing.  They 73 
include the presence of a behavioural trait that prevented feeding on rodenticide baits in Hampshire 74 
resulting in reduced intake of the active substances, a second additive resistance mechanism not 75 
related to the conventional resistance gene and the possible selection in field populations of an 76 
advanced form of resistance, caused by the repeated use of resisted rodenticides, which meant that 77 
the laboratory strains tested by Greaves and Cullen-Ayres had been superseded.  It subsequently 78 
transpired that each of these explanations was at least partially relevant. 79 
Following the development of the ‘selected line’, carrying the strongest resistance phenotype then 80 
known (Greaves and Cullen-Ayres, 1988), a resistance feeding test was developed for one of the 81 
most potent anticoagulants available, brodifacoum, involving bait containing 5 ppm of the active 82 
substance (Gill and MacNicoll, 1991).  Animals that survived consumption of this bait for seven days 83 
were termed ‘brodifacoum-resistant’.  The somewhat illogical implication of this was that rats 84 
declared ‘brodifacoum resistant’ were likely to be fully susceptible during field operations because 85 
these employed commercial baits carrying 50 ppm of the active substance.  Several hundred wild-86 
caught rats from the difenacoum resistance area were tested using the brodifacoum resistance test 87 
and a single male survivor was used to found a selected ‘brodifacoum-resistant’ laboratory strain.  88 
The form of resistance it exhibited was termed ‘low-grade’ and, as the farms from which these 89 
animals were taken were in Berkshire, the strain came to be called “Berkshire-resistant” (Gill et al., 90 
1992).  However, breeding studies showed that this resistance was not genetically stable in the same 91 
way as other resistance mutations known at the time (Gill et al., loc. cit.). 92 
Research also continued in the field, particularly to investigate the influence of rat behaviour on 93 
treatment efficacy within the difenacoum resistance focus.  Differences were found between the 94 
responses of rats to both poisoned and unpoisoned baits in the Welsh and Hampshire resistance 95 
areas (Quy et al., 1992).  Rats readily consumed novel foods such as rodenticide baits on Welsh 96 
farms, with consequent rapid control of entire infestations.  While in Hampshire rats were often 97 
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reluctant to consume novel foods, resulting in control being delayed for many weeks.  There was 98 
also frequent failure on these farms to achieve complete control.  These differences were attributed 99 
to rat behavioural responses to farming practices and the structures of the farmsteads themselves.  100 
In Wales, mixed arable and livestock farms (mainly dairy and sheep) present highly disturbed 101 
environments, where food sources and harbourage change frequently.  In such situations, rats 102 
quickly overcome their suspicion of novel objects and new foods to acquire the resources they need.  103 
There was little animal husbandry on many Hampshire farms and farmsteads presented habitats 104 
where food sources, often bulk grain flat-stores (i.e. large quantities of cereals held in metal-sided 105 
bins on concrete floors), were stable over long periods.  Rats established feeding patterns 106 
undisturbed and were reluctant to divert their feeding onto novel food, such as rodenticide baits, 107 
and away from known, stable and abundant alternative food resources (Quy et al., loc. cit.). 108 
The UK regulatory framework throughout this period, and indeed until 2016, was one wherein only 109 
bromadiolone and difenacoum were effectively available for the control of anticoagulant-resistant 110 
Norway rats.  Concerns about the potential environmental effects of the more potent resistance-111 
breakers, brodifacoum, flocoumafen and, latterly, difethialone, had resulted in their restriction to 112 
use indoors only (HSE, 2012).  This restriction virtually precludes their use against rat infestations 113 
because usually the greater part of these reside outdoors (Buckle, 2013).  Finally, carefully 114 
monitored applications of bromadiolone bait on a farm in West Berkshire proved entirely ineffective, 115 
with 830 kg of bait consumed on the farm over an eight month period, resulting in no measurable 116 
reduction in the size of the infestation (Quy et al., 1995).  The use of bait markers revealed that one 117 
rat survived the consumption of at least 450 g of bromadiolone bait.  Such a massive environmental 118 
emission of a second-generation anticoagulant, when replicated elsewhere in anticoagulant 119 
resistance foci, because the more potent resistance-breaking compounds could not be used, may go 120 
some way to explain both the large current extent of resistance foci in the UK and the prevalence of 121 
residues of bromadiolone and difenacoum in UK wildlife (Buckle, 2013; Shore et al., 2015; Jones et 122 
al., 2019). 123 
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The genetic basis of Norway rat anticoagulant resistance mutations was revealed to be a series of 124 
SNPs in the VKORC1 gene located on chromosome 1 (Rost et al., 2004).  Pelz and his co-workers 125 
showed that rats from the Hampshire-Berkshire focus possess the L120Q SNP (Pelz at al., 2005; Pelz 126 
and Prescott, 2015).  However, the research cited above appeared to show that there is more than 127 
one resistance phenotype at this focus, with Berkshire-resistant rats having a higher level of 128 
resistance to anticoagulants than Hampshire-resistant rats but each possessing the same resistance 129 
SNP.  The presence of a second resistance mechanism was postulated to explain this (Buckle, 2013), 130 
and it was later found that elevated CYP450-oxidative metabolism, leading to an accelerated 131 
anticoagulant detoxification, is involved in the Berkshire phenotype (Boitet et al., 2018).  A 132 
mechanism of enhanced metabolism and clearance of anticoagulants, involving CYP450 enzymes, 133 
was also found to explain some characteristics of bromadiolone resistance in Norway rats from 134 
Denmark (Markussen et al., 2008). 135 
The purpose of the field trials described here was to test the efficacy of proprietary bromadiolone 136 
and difenacoum formulations against the anticoagulant-resistant Norway rat genotype present at 137 
the heart of the Hampshire/Berkshire resistance focus in 2008.  No similar trials had been conducted 138 
since 1991 (Quy et al., 1995).  For the first time, the treated populations were screened for the 139 
resistance mutation they carried using the (then) new DNA sequencing method (Pelz at al., 2005).  140 
After the difenacoum and bromadiolone trials had been completed, the intention was to test the 141 
effectiveness of a proprietary brodifacoum formulation in anticipation that this more potent active 142 
substance might offer both a practical solution to resistance in this focus and the potential to reduce 143 
wildlife exposure to second-generation rodenticides.  However, since outdoor bait applications were 144 
needed, permission for the brodifacoum field trials was required from the UK biocides regulatory 145 
body, the Health and Safety Directorate (HSE).  This permission was denied on the grounds that the 146 
risk to the environment of the two trials, acknowledged to be limited, was not justified by their 147 
anticipated scientific value.  Therefore, the brodifacoum trials presented here could not be 148 
attempted until eight years later; after the removal in 2016 of the ‘indoor-only’ regulatory restriction 149 
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on brodifacoum (and consequently also on the other potent, resistance-breaking anticoagulants, 150 
difethialone and flocoumafen).  In the interim period, the use of bromadiolone and difenacoum 151 
baits, shown in these trials to be largely ineffective, was the major anticoagulant intervention 152 
permitted to those whose premises were infested by resistant Norway rats.  This likely had 153 
important consequences for resistance management, resistance spread and the exposure of wildlife 154 
to rodenticides (Daniells et al., 2011; Buckle, 2013). 155 
Recent resistance surveys have revealed that the original Hampshire/Berkshire resistance focus has 156 
apparently spread widely from the areas where it was first discovered and now covers most of 157 
central southern England (Greaves and Rennison, 1973; Jones et al., 2019).  There is also evidence of 158 
pockets of this resistance in many other parts of the UK, including East and West Sussex, Wiltshire, 159 
Somerset, Devon, Monmouthshire, Yorkshire and the counties of East Anglia (Rodenticide Resistance 160 
Action Committee http://www.rrac.info/).  It is impossible to know whether these have become 161 
established either as a result of the transportation of resistant rats from original foci or from de novo 162 
mutation events.  In any case, the lessons learned about the use of rodenticides against rats carrying 163 
the L120Q mutation during this study are now more widely relevant. 164 
2. MATERIALS AND METHODS 165 
2.1 Trial sites 166 
General 167 
The trial sites were working farms in West Berkshire and north-west Hampshire, within the L120Q 168 
resistance focus (Jones et al., 2019).  Each site differed from the others in the composition of 169 
livestock and farming practices (see below), although they were typical of farm enterprises in the 170 
area that had been previously used for field trials of anticoagulant rodenticides (Greaves et al., 171 
1992b; Quy et al., 1995; Cowan et al., 1995).  All were infested with Norway rats, living 172 
predominantly outside the farm buildings, although in very close proximity to them.  Another 173 
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common feature was that there were plentiful food sources and harbourage for rats, although few 174 
of these could be eliminated given conventional farm practices involving ad libitum feeding of 175 
livestock and the methods of storing cereal grains on-farm.  All of the infestations were 176 
circumscribed with very little sign of movement of rats onto the farms from neighbouring areas, 177 
though in some places low-level infestations were to be found in neighbouring hedgerows, as is 178 
normal for the rural landscape of Hampshire and Berkshire.  All who operated these enterprises had 179 
expended considerable resources in rodent pest management.  These efforts mostly involved baiting 180 
with either the permitted difenacoum or bromadiolone baits, in conjunction with burrow fumigation 181 
and trapping.  Two of the sites were under contract to a reputable commercial pest control 182 
company, but all had achieved only partially satisfactory control of rat infestations. 183 
Site 1. Large dairy unit, nr. Stockbridge, Hampshire 184 
The site comprised a large, modern milking parlour and four large open barns in which 185 
approximately 600 dairy cattle were housed in sheds set on a concrete apron.  Other infested 186 
buildings included a feed store, concrete bunkers in which maize silage was stored, a vehicle shed 187 
and barns used for housing calves and storing straw bales.  The moderate rat infestation was mainly 188 
feeding on the silage maize available from the cattle stalls and concrete bunkers.  The site was very 189 
clean and well-kept, with limited availability of harbourage for rats.  Rat burrows were mainly found 190 
on waste ground bordering the site, beneath the concrete foundations of buildings and areas of 191 
disturbed ground. 192 
Site 2. Small mixed farm, nr. Welford, West Berkshire 193 
The site involved a machinery barn, two smaller barns used for grain storage, a large barn used for 194 
vehicle parking and the storage of grain used in pheasant feeders and a Dutch barn with straw bales.  195 
In the centre of the site were two rows of pig-sties containing about 100 sows and piglets.  The 196 
farmstead was in a poor state of maintenance, with large areas of overgrown vegetation around the 197 
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site and between the buildings.  Food was continuously available for the heavy rat infestation in the 198 
pig stalls, at a flat store of whole wheat grains used for pheasant feeding and from spillage in a 199 
granary and milling barn.  Rats had found harbourage in and around the buildings and barns across 200 
the site. 201 
Site 3. Large free-range poultry unit, nr. Stockbridge, Hampshire 202 
The site comprised thirteen large free-range poultry sheds, with raised floors above compacted 203 
earth bases.  The sheds accommodated approximately 15,000 birds and applied high standards of 204 
animal welfare, cleanliness and biosecurity.  However, the moderate rat infestation had continuous 205 
access to food from the chicken feed hoppers in each of the poultry sheds and, to a limited degree, 206 
from the spillage at augers and feed silos across the site.  A long hedge ran down the entire north-207 
east border of the site with rat burrows along its length and there were rat runs and burrows around 208 
and under the poultry sheds. 209 
Site 4. Large mixed farm, nr. Wickham, West Berkshire 210 
The site comprised three large barns for pigs, cattle and sheep and further barns for machinery and 211 
equipment, grain and straw bales.  In addition there was a neighbouring hanger for light aircraft and 212 
several smaller buildings with varying uses.  The farm was well-maintained although there were 213 
neglected areas and grain spillage in a storage barn and mill.  There was evidence of rat infestation 214 
across the site; although mainly restricted to the farm buildings, there was evidence of low-level 215 
infestation in hedgerows leading away from the building in which pigs were housed. 216 
Site 5. Small dairy unit, nr. Reading, West Berkshire 217 
The site consisted of an office building, with a large shed for the intensive feeding and milking of 218 
cattle and a smaller shed for dairy cows.  Pheasants were present throughout the site, particularly 219 
where there was woodland cover.  There was evidence of rats being present, with runs and burrows 220 
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in several areas and live rats seen around the site.  Food resources for rats were available at the site 221 
at feeding troughs provided for sheep and cattle. 222 
Site 6. Small mixed farm, nr. Basingstoke, Hampshire 223 
The site comprised a residential house, an adjacent workshop, a large open pen for chickens and 224 
geese, and four barns which housed cows, sheep, hay and straw bales.  There were abundant signs 225 
of a substantial rat infestation, with rat runs and rat burrows in all areas and with live rats frequently 226 
seen.  Feeding troughs for sheep, cattle and chickens gave rats access to feed and feed stored in 227 
polymer bags in one of the barns was also accessible. 228 
2.2 Laboratory resistance studies 229 
Following preliminary site surveys, initial work was conducted on all of the farmsteads to obtain 230 
information on the resistance status of their Norway rat infestations prior to the commencement of 231 
the bait applications.  Blood-clotting response (BCR) tests were conducted on rats from four of the 232 
farms (sites 1-4) during 2009/2010 to assess the degree of resistance to anticoagulants they 233 
exhibited and, in particular to compare current resistance factors with those published previously 234 
based on feeding tests (Greaves and Cullen-Ayres, 1988).  For this, a standard protocol was 235 
employed which involved the administration by gavage of solutions containing various 236 
concentrations of bromadiolone and difenacoum, subsequent removal of blood samples under 237 
anaesthesia and assessment of blood clotting responses (BCR) (Prescott et al., 2007). 238 
Tissue samples from rats on all of the farms were taken for DNA extraction and sequencing.  On four 239 
of the farms (sites 1-4) rats were trapped prior to the treatments specifically for this purpose.  Dead 240 
rats were collected both prior to and during the progress of the poison baiting treatments on the 241 
other two farms (sites 5 and 6).  The procedures used to detect the presence or absence of 242 
anticoagulant resistance DNA mutations were similar to those described by Prescott et al. (2007) 243 
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and, although only the L120Q mutation was subsequently found, all other rat resistance mutations 244 
known to be present in the UK would have been found had they been present. 245 
2.3 Test substances 246 
The rodenticide bait formulations tested in the trials are shown in Table 1.  Two of the baits were 247 
commercially available pellet formulations, one contained 50 ppm bromadiolone (Contrac®) and the 248 
other 50 ppm difenacoum (Ratak®).  The remaining two formulations both contained brodifacoum as 249 
an active substance.  One was a 20 g wax block experimental formulation, containing a nominal 23 250 
ppm of the active substance, and the other a commercial pellet formulation containing the same 251 
concentration of brodifacoum (Talon®).  All the test baits, both proprietary and experimental, 252 
contained 10 ppm of the human taste deterrent denatonium benzoate (Kaukeinen and Buckle, 253 
1992). 254 













Pellet (commercial) difenacoum 50 ppm 1 and 2 100-300 Twice weekly 
Pellet (commercial) bromadiolone 50 ppm 3 and 4 150-300 Twice weekly 
Wax block (20g) 
(experimental) 
brodifacoum 23 ppm 5 20-60 Three times 
weekly 
Pellet (commercial) brodifacoum 23 ppm 6 50 Three times 
weekly 
Table 1.  Rodenticide baits used, the concentrations of the active substance, application rates and 255 
the frequency of bait replenishment in the six field trials. 256 
2.4 Field efficacy tests 257 
The experimental programme was carried out in two phases for the reason given above.  Trials 1-4 258 
were conducted during the period February 2009 to January 2010.  Trials 5 and 6 were conducted 259 
from April to December 2016. 260 
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The field trial protocol closely followed that used in similar studies of anticoagulant rodenticide 261 
efficacy (Endepols et al., 2011; Buckle et al., 2012) and was in accordance with published guidelines 262 
from international agencies including the European and Mediterranean Plant Protection 263 
Organisation (EPPO, 1998), the European Commission (EC, 2011) and the European Chemicals 264 
Agency (ECHA, 2017a).  The protocol was based on the application of poisoned baits according to 265 
their regulatory label requirements, or as otherwise advised by the manufacturers.  Evaluations of 266 
efficacy relied on two different indirect assessments of the size of the rodent infestation applied in a 267 
similar manner before and after the treatment, namely census baiting and the measurement of 268 
tracking activity (Quy et al., 1993).  In preparation for the field trials, the six sites were surveyed and 269 
scale maps were drawn.  A thorough search of each site was conducted for the bodies of any Norway 270 
rats and non-target animals prior to bait applications and any bodies found were removed. 271 
The field trial schedule comprised three main phases, each separated from the other by a lag period 272 
during which no activities were undertaken at the sites.  The first phase involved a pre-treatment 273 
census, generally four-days in duration, in which census baiting and tracking were used to estimate 274 
the initial size of the rat infestations.  The numbers of census bait points and tracking patches set out 275 
at the six sites are shown in Table 2.  On the first day of the pre-treatment census, the wooden 276 
census bait trays were filled with 200g of whole dry wheat, and the sand tracking patches, each 277 
approximately 100 mm by 150 mm, were smoothed over.  The census bait was weighed (± 1g) and 278 
replenished daily.  Where complete takes of census bait occurred, the quantity of census bait put 279 
down at replenishment visits was doubled.  This resulted in 800 g of bait on some bait points in 280 
heavily infested areas.  The tracking patches were recorded and smoothed over daily for four 281 
consecutive days.  The tracking patches were scored using the following scale: 0 = no signs of rodent 282 
tracks; 1 = 1-5 rodent tracks, 2 = >5 tracks and up to 25% of patch covered with footprints; 3 = 26 – 283 
95% covered; 4 = >95% covered.  A lag period of not less than four days was used to separate the 284 
pre-treatment census period from poisoned baiting to permit the rats to return to their usual foods 285 
and feeding places. 286 
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Site Dates of trial Active substance No. tracking 
patches 




1 13.02.2009-08.05.2009 difenacoum 45 58 57 
2 26.10.2009-24.01.2010 difenacoum 39 82 90 
3 13.02.2009-21.04.2009 bromadiolone 54 78 77 
4 26.10.2009-24.01.2010 bromadiolone 46 94 97 
5 18.04.2016-29.07.2016 brodifacoum 35 50 55 
6 05.05.2016-23.12.2016 brodifacoum 32 50 90* 
Note: * 41 rat burrows were also baited for a 13-day period. 
Table 2. The dates of trials, numbers of tracking, census bait and poisoned bait points used on the six 287 
farms. 288 
The second phase was that of poisoned bait application.  The difenacoum and bromadiolone baits 289 
were applied according to the regulatory labels found on the product packs.  These permitted a 290 
range of bait quantities (100-300g) to be placed at each bait point.  Initial bait point sizes were 100 g 291 
per point but this quantity was increased either when complete takes occurred or when the take of 292 
bait at a replenishment visit was found to have approached a complete take.  Conversely, when 293 
takes of bait declined the quantity of bait set out was reduced to the minimum permitted.  The 294 
applications of brodifacoum baits were of much smaller quantities, with either one to three 20 g 295 
blocks per bait placement (i.e. 20-60 g) or 50 g of pellet bait placed at each bait point, and 296 
replenishment visits three times per week. 297 
The sites of the poisoned bait placements once again followed label instructions and were 298 
determined according to the intensity and distribution of signs of rat activity so that, so far as 299 
possible, all rats present had access to a nearby baiting point.  Bait points were protected with 300 
materials available at the sites, such as pipes, bricks, wooden beams, corrugated metal sheeting and 301 
other materials.  The use of locally-available materials for securing baiting points provides more 302 
rapid and greater uptake of bait than from purpose-made tamper-resistant bait boxes (Buckle and 303 
Prescott, 2011).  However, specially-constructed wooden bait boxes (measuring approximately 304 
31x22x14.5 cm, with two rectangular entrances of approximately 7.5x5 cm) were used where 305 
insufficient material for robust protection of baits was found at the sites.  Plastic bait boxes were 306 
also used, having approximate dimensions of 27x18x12 cm, with two circular entrances with a 307 
14 
 
diameter of 9 cm.  On some sites, when it became apparent that rats were present but were 308 
reluctant to feed from the covered bait stations, some baits were put directly into rat burrows.  All 309 
bait points were inspected according to the treatment schedule and, at each visit, the remaining bait 310 
was weighed and replenished when necessary.  An assessment of tracking activity continued 311 
throughout the poison baiting period, with recorded track scores being the aggregate score over the 312 
several days that separated baiting visits. 313 
The trials ended with the completion of the third phase, the post-treatment census.  This was 314 
conducted in a manner that was as similar as possible to that used in the pre-treatment census. 315 
The basis for the calculations of the efficacy of treatments was a comparison between information 316 
obtained in the pre- and post- treatment census periods as follows (EPPO, 1998): 317 
  % efficacy = pre-treatment activity – post-treatment activity * 100 318 
    pre-treatment activity 319 
3. RESULTS 320 
3.1 Resistance tests 321 
Resistance tests based on BCR methodology (Prescott et al., 2007) were conducted to estimate the 322 
magnitude of resistance to second-generation anticoagulants at four of the trial sites (Table 3).  323 
Female animals were given a dose eight times and six times greater than the susceptible ED50 for 324 
bromadiolone and difenacoum respectively, and male animals were given a dose three times the 325 
susceptible ED50 for both active ingredients and, 24 hours later, a high proportion of the animals 326 
were found to be non-responders.  In almost all cases, the percentage of non-responders was 327 
greater than 50%, thus indicating female RFs of at least 8 and 6 for bromadiolone and difenacoum 328 
respectively, and male RFs of at least 3 for both active ingredients; a magnitude of resistance that is 329 
greater than that previously reported for both males and females for these substances using feeding 330 











1 bromadiolone Female (n=10) 5.00 mg.kg-1 
(8xED50) 
70.0 
Male (n=7) 1.41 mg.kg-1 
(3xED50) 
71.0 
difenacoum Female (n=9) 4.74 mg.kg-1 
(6xED50) 
44.4 





















3 bromadiolone Female (n=5) 5.00 mg.kg-1 
(8xED50) 
40.0 
Male (n=8) 1.41 mg.kg-1 
(3xED50) 
100.0 
difenacoum Female (n=1) 4.74 mg.kg-1 
(6xED50) 
100.0 
4 bromadiolone Female (n=6) 5.00 mg.kg-1 
(8xED50) 
33.3 
Male (n=2) 1.41 mg.kg-1 
(3xED50) 
50.0 
difenacoum Female (n=11) 4.74 mg.kg-1 
(6xED50) 
63.3 
Male (n=13) 1.95 mg.kg-1 
(3xED50) 
53.4 
Table 3.  The results of the blood clotting response tests conducted on rats from four of the six 332 
treated farms.  Doses administered are shown as both absolute values and as multiples of the ED50 333 
for fully susceptible animals. Dates of the trials are given in Table 2. 334 
Table 4 provides a summary of the DNA resistance tests that were conducted on a total of 111 rats 335 
taken from the farms.  Tissue samples from four rats could not be sequenced.  Among the others, 336 
only one individual did not carry the L120Q SNP; thus the frequency of resistance on the six farms 337 
was 99.1%.  The incidence of homozygosity was also very high (86.9%).  Such results are likely to be 338 
obtained where there has been a prolonged selection for the resistance trait caused by the frequent 339 
use of resisted anticoagulants. 340 
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Heterozygous Homozygous Sequencing 
failed 
% resistant 
1 32 0 1 30 1 100.0 
2 27 0 3 24 0 100.0 
3 13 0 1 12 0 100.0 
4 20 0 2 18 0 100.0 
5 9 1 1 5 2 85.7 
6 10 0 5 4 1 100.0 
totals 111 1 13 93 4  
Table 4.  Results of DNA sequencing for the L120Q resistance mutation among rats taken from the 341 
trial sites.  Dates of the trials are given in Table 2. 342 
3.2 Efficacy of rodenticide treatments 343 
Site 1. Large dairy unit, nr. Stockbridge, Hampshire 344 
The survey of the farm had revealed a widespread infestation across the site, with a particular centre 345 
of activity around the barn that housed the calf stalls, stacks of straw bales and farm machinery.  346 
Therefore, the very low take of census bait of just 174 g on the first day of the trial was unexpected 347 
and indicated that the rats on the site were reluctant to switch their feeding to novel alternative 348 
foods.  Census bait takes increased rapidly (Fig. 1), however, but it was considered by the fourth day, 349 
when the census would normally have been terminated, that bait take (1.37 kg) still did not provide 350 
a realistic assessment of the size of the population.  Therefore, census baiting was conducted for a 351 
further two days at which time the daily consumption of wheat bait had increased to 2.20 kg.  It 352 
seems likely that the take of census bait would have continued to increase had the census been 353 
continued for longer and, therefore, the size of the initial infestation may have been 354 
underestimated.  It was also noticeable throughout the census that almost all bait consumption was 355 
from bait stations constructed from natural materials and very few takes were recorded from bait 356 
boxes, either of the wooden or plastic designs.  The highest daily pre-treatment consumption of 357 



































1* 6.87 2.20 242 55 7.89 1.86 286 58 
2 33.36 10.57 418 115 13.20 4.20 169 45 
3 9.20 2.73 154 43 2.83 0.92 94 27 
4 15.07 5.49 285 84 17.80 5.57 323 87 
5 4.88 1.37 172 50 0.02 0.01 0 0 
6 9.78 3.18 336 96 0.05 0.03 4 3 
Note: * pre- and post-treatment census periods of six days at site 1. 
Table 5.  Results of pre- and post-treatment census baiting and tracking at the six experimental sites. 359 
 360 
If certain assumptions are made about the rat infestation, it is possible to estimate the number of 361 
individuals present at the site from the quantity of census bait consumed.  These assumptions are: 1) 362 
rats consume only census bait during the baiting period, 2) rats have a mean weight of 200 g, 3) 363 
Norway rats consume 10% of their body weight in dry food each day.  These assumptions, and the 364 
maximum daily census bait take of 2.20 kg, result in an estimated population size of 110 rats.  Such 365 
estimates are conservative as it is very unlikely, given the known neophobia of Norway rats and the 366 
presence of abundant alternative food sources at trial sites, the rats fed exclusively from the census 367 
bait (Barnett, 1958; Inglis et al., 1996). 368 
The 50 ppm difenacoum pellet poisoned bait was applied according to the manufacturer’s label 369 
instructions, following a lag period.  Once again, initial takes of this bait were poor, and certainly less 370 
than might have been expected from the apparent size of the infestation, although they showed a 371 
steady increase over the first 20 days of the treatment.  Thereafter, and until the treatment was 372 
terminated after 48 days of baiting, takes of poisoned bait fluctuated between replenishment visits 373 
from approximately 2 kg to 3 kg (Fig. 1).  During the treatment period, track scores fluctuated 374 
between 37 and 61, but it should be noted that these scores are not directly comparable with the 375 
daily track scores recorded during the pre-treatment period because they are the accumulate track 376 
score for either three or four days. 377 
The post-treatment was conducted after a lag period of six days and the maximum daily take of 378 
census bait (1.86 kg) was recorded on the last of the six days of census baiting.  The maximum daily 379 
track score, also recorded on the sixth day, was 58 (Table 5). 380 
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During the treatment the estimated total quantity of poisoned bait consumed by the rat infestation 381 
was 28.57 kg (Table 6).  The maximum daily quantities of census bait consumed during the pre- and 382 
post-treatment census periods were used in the equation shown above to estimate that treatment 383 
efficacy at 15.5% mortality.  The maximum daily track scores were similarly used and provided an 384 
estimate that the rat infestation at the site had grown by 5.5% during the treatment period. 385 






















1 difenacoum (50ppm) 2.20 (110) 28.57 1.43 15.5 +5.5 
2 difenacoum (50ppm) 10.57 (529) 59.24 2.96 60.3 60.9 
3 bromadiolone (50 ppm) 2.73 (136) 17.67 0.88 66.3 37.2 
4 bromadiolone (50 ppm) 5.49 (275) 43.19 2.16 +1.5 +3.6 
5 brodifacoum (23 ppm) 1.37 (69) 4.38 0.10 99.3 100.0 
6 brodifacoum (23 ppm) 3.18 (159) 9.68† 0.22 98.4 96.9 
Notes: 
§
 values in brackets are the estimated numbers of rats present at the start of the treatments 
(assumptions are given in the text) 
 * mortality estimates preceded by + indicate estimated population growth during treatment 
 † includes burrow bait that was applied but some of which was probably not consumed 
Table 6. The results of efficacy assessments conducted at the six trial sites.  The maximum daily pre-386 
treatment census bait take is shown as an indirect measure of the sizes of the initial infestations. 387 
Site 2. Small mixed farm, nr. Welford, West Berkshire 388 
Initial takes of census bait at site 2 were high, indicating that the rat infestation exhibited little or 389 
none of the bait shyness that had been seen at site 1 (Fig. 1).  This was in spite of abundant 390 
alternative food at the site (section 2.1).  Similarly, the rats readily entered the wooden bait boxes 391 
used from the first day of the census.  These observations demonstrated that differences in the 392 
behaviour of the field infestations may influence both treatment durations and treatment outcomes.  393 
A total of 33.36 kg of census bait was consumed over four days of the pre-treatment census baiting, 394 
with a maximum daily take of 10.57 kg.  The total track score for the four days was 169, with a 395 
maximum of 45 recorded on the last day of the census (Table 5).  Using the same assumptions 396 
described above, an estimated population size of 529 Norway rats infested the site. 397 
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The takes by rats of difenacoum pellets at site 2 were also initially high, as might be expected from a 398 
large infestation showing little or no reluctance to take apparently highly palatable bait.  For 399 
example 9.96 kg of bait were eaten over the first five days of baiting.  Bait takes declined over the 400 
following 14 days (Fig. 1) and thereafter continued at a fairly constant rate for a period of about 401 
three weeks.  This pattern of bait take may occur when a resistant infestation is treated with a 402 
resisted anticoagulant.  The more susceptible animals succumb to the bait initially, particularly when 403 
bait takes are good, leaving only the more resistant animals remaining to continue feeding.  It is this 404 
process which increases the incidence of resistance mutations within resistant populations, as well 405 
as the severity of resistance.  After 35 days of baiting, it became apparent both from the quantities 406 
of poisoned bait taken and the track score (Fig. 1) that little further progress would be made and the 407 
treatment was discontinued. 408 
The post-treatment census began, following a four-day lag period, but a very heavy fall of snow 409 
overnight prevented access to the farm on the third day of the census and for seven days thereafter.  410 
Eventually, the census bait was removed and a second, five-day lag period was applied before the 411 
census bait procedure began again.  Overall, 19 days separated the removal of the poisoned bait and 412 
the commencement of the second census period.  Given the extremely cold weather and the deep-413 
laying snow, it seems unlikely that the rat infestation remaining on the farm was significantly 414 
supplemented by either immigration or breeding. 415 
The results of this census are shown in Fig. 1.  The maximum census bait take (4.20 kg) was recorded 416 
on the fourth night of the census and the maximum track score of 45 was recorded on the third 417 
night.  These data were used to obtain estimates of rat mortality achieved by the treatment of 418 
60.3%, using census baiting, and 60.9% using track scores. 419 
Site 3. Large free-range poultry unit, nr. Stockbridge, Hampshire 420 
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The Norway rats at this site apparently took the census bait without reluctance and there were good 421 
takes across the entire area.  The maximum daily census bait consumption, 2.73 kg, was recorded on 422 
the fourth night of the census but the takes for the two preceding nights were not much less (Fig. 1).  423 
The maximum track score was 43 on the second night of the census.  The census bait take was used 424 
to estimate the rat infestation at 136 rats, making as before the somewhat unlikely assumption that 425 
the rats only ate census bait.  Takes of poisoned bait were initially good and a total of 6.80 kg of 426 
bromadiolone bait was consumed during days four to seven of the application.  However, bait takes 427 
fell rapidly thereafter and continued at a regular, but considerably, lower level for the remaining 428 
period of the treatment.  After 35 days of poisoned baiting it became apparent, from the continuing 429 
low level takes of poisoned bait and track score, that little further reduction of the infestation would 430 
be achieved and the treatment was therefore terminated. 431 
The post-treatment census monitoring was initiated and was conducted in the same way as the pre-432 
treatment census, using the same tracking patch and bait point locations.  The four-day post-433 
treatment tracking patch census was assessed daily, and produced a total census score of 94 and a 434 
maximum on day four of the census of 27 (Fig. 1).  The post-treatment census bait consumption was 435 
measured daily for four days, and resulted in a total bait take of 2.83 kg, with a maximum take of 436 
0.92 kg on the third day of the census (Table 5).  These records provided estimates of the percentage 437 
mortality of rats at the site caused by the bromadiolone treatment of 66.3% using census baiting and 438 
37.2% using the track score values.  There was no obvious explanation for the difference between 439 
these two values but it is usually considered that mortality estimates derived from census bait data 440 
are more reliable than those obtained from track scores. 441 
Site 4. Large mixed farm, nr. Wickham, West Berkshire 442 
The consumption of census bait on site 4 followed a usual pattern in which takes increase during the 443 
four-day census period.  Consumption was good on the first day of baiting, when the rats consumed 444 
2.10 kg of bait overnight, but increased steadily until 5.49 kg were consumed on the fourth night of 445 
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the census (Table 5).  It seems likely that census bait take would have continued to rise had the 446 
census continued for a longer period.  The number of rats present at the site was conservatively 447 
estimated, from census bait consumption, to be 275 individuals.  The total track score during the 448 
four-day census was 285, with a maximum of 84 on the fourth day of the census. 449 
Takes of bromadiolone bait were initially high, with a total of 7.67 kg of bait consumed during the 450 
first four days of the treatment (Fig. 1).  The average daily consumption of 1.92 kg was, however, less 451 
than the average daily consumption of census bait of 3.75 kg.  During the period of poisoned baiting 452 
a pattern was observed in which consumption of bait remained high but showed a steady decline.  453 
Given the high quantities of bait consumed, it is likely that some rats would have died during this 454 
period, resulting in the observed decrease in both bait take and track score (Fig. 1).  However, total 455 
bait takes were 7.57 kg and 5.12 kg respectively in the fourth and fifth weeks of the treatment and 456 
track scores showed an increase.  The decision was therefore made to terminate the treatment after 457 
35 days of poisoned baiting and a total consumption by the rats at the site of 43.19 kg of 458 
bromadiolone bait (Table 6). 459 
The work at site 4 was carried out synchronously with that nearby on site 2 and the post-treatment 460 
census period was similarly disrupted by a very heavy fall of snow.  When the post-treatment census 461 
was carried out it resulted in a maximum daily take of census bait of 5.57 kg and a maximum daily 462 
track score of 87 (Table 5).  When these values were used to assess the effectiveness of the 463 
bromadiolone treatment, both resulted in an estimated growth of the infestation, of 1.5% and 3.6% 464 
for census baiting and track score respectively (Table 6). 465 
Site 5. Small dairy unit, nr. Reading, West Berkshire 466 
The infestation at this site was apparently the smallest of those present among the six trial sites.  A 467 
total of 4.88 kg of census was consumed over four days, with the maximum 1.37 kg taken on the 468 
fourth day.  This value provides a conservative estimate of 69 rats at the site.  The nature of the site, 469 
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the fact that the activity of the infestation was mainly focussed outdoors and the frequent rain that 470 
occurred during the trial, made it difficult to establish tracking patch points that remained dry and 471 
capable of recording rat foot-prints throughout the census.  However, a total track score of 172 was 472 
recorded, with a maximum daily score of 50 on the fourth day of the census. 473 
The consumption of the brodifacoum wax blocks was initially poor, with only 210 g of bait eaten in 474 
the first two days of baiting.  This may have been due either to the initial inability of the rats to 475 
recognise the blocks as food or, if they were recognised as food, a reluctance to consume them.  476 
However, bait takes then increased and reached a maximum at the end of the first week of baiting, 477 
when more than a kilogramme of bait was consumed over three days (Fig. 1).  Thereafter, bait takes 478 
declined quickly, as did the tracking score, indicating that the rat infestation was being quickly 479 
extinguished.  After three weeks of baiting, both bait takes and track score had reached very low 480 
levels.  Unfortunately, at this time field signs at some bait stations indicated that a portion of the 481 
continuing activity observed may have been due to grey squirrels (Sciurus carolinensis).  Camera 482 
traps were deployed and confirmed that this was the case.  Grey squirrels are, of course, non-target 483 
animals in the context of outdoor baiting with anticoagulants and, therefore, bait was immediately 484 
removed from the site and the trial paused.  Five squirrels were subsequently humanely trapped and 485 
removed from the site and the trial resumed.  The duration of the pause was 24 days, but baiting 486 
continued thereafter for a further 18 days, until both track scores and bait takes were reduced to 487 
zero.  Bait takes from stations that are considered likely to have been visited by squirrels were 488 
subtracted from the estimated total consumption of poisoned bait. 489 
As in previous trials, the post-treatment census was carried out in the same way as the pre-490 
treatment census.  No activity was detected on any tracking patches, giving an estimate of mortality 491 
by that method of 100%.  However, there were several very small takes of census bait, amounting to 492 
a total of 21 g over the four-day census period.  Although it was likely that these takes were by 493 
either wood mice (Apodemus sylvaticus) or bank voles (Myodes glareolus), it was not possible from 494 
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the field signs entirely to dismiss the likelihood that they were small rat takes.  Therefore, the 495 
estimate of mortality brought about by the application of 23 ppm brodifacoum wax blocks at site 5, 496 
using census baiting, was estimated to be 99.3%. 497 
Site 6. Small mixed farm, nr. Basingstoke, Hampshire 498 
Rats at site 6 ate more than 1.5 kg of wheat bait on the first day of census baiting, indicating that 499 
they were not reluctant to take a novel foodstuff.  Bait takes increase daily until, on the last day of 500 
census baiting, the take of bait reached 3.18 kg, with a total consumption over the four days of 501 
baiting of 9.78 kg.  The daily bait take provides, using the same assumptions as before, an estimate 502 
of 159 rats.  The maximum track score during the pre-treatment census was 96. 503 
Takes of the 23 ppm brodifacoum pellet bait were initially very good, with a total take of more than 504 
2.5 kg over the first three days of baiting.  Thereafter, takes of bait declined quickly during the 505 
following two weeks (Fig. 1).  However, although the track score also showed a decline, its degree 506 
did not match that seen in the poisoned bait take data.  About three weeks into the treatment it 507 
became apparent that rats remained active at the site but they were not taking the poisoned bait.  508 
Any open rat burrows seen were blocked and it was found that a considerable number of rat 509 
burrows remained active around an outdoor pen where poultry was kept and fed ad libitum.  A 510 
normal procedure in this case during a conventional treatment would be to employ burrow baiting, 511 
in an attempt to induce the rats to take bait.  However, although it is possible to record the quantity 512 
of bait put out in burrow baiting, it is not possible to estimate bait consumption, as is desirable in a 513 
monitored rodenticide trial.  Therefore, conventional baiting continued for another week in the 514 
hope that the infestation could be extinguished.  When this did not occur, burrow baiting was first 515 
employed on day 30 of the application.  A total of 41 burrows were treated with 50 g of pellets each 516 
and burrows which remained active between treatment visits were baited until day 43 of the 517 
treatment.  These burrow baits were included in the calculations of the quantities of bait applied but 518 
it seems likely that at least some of this bait was not consumed by rats. 519 
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The post-treatment census began after a five-day lag period.  Census bait take was observed on two 520 
of the four census days, with a maximum of 32 g of bait eaten on the fourth and final day.  Similarly 521 
tracking activity was observed on two days, with a maximum score of 3 on the first day of the 522 
census.  Once again, it was impossible from the field signs to preclude the possibility that these takes 523 
were by rats and, therefore, these data provide estimates of mortality of 98.4% and 96.9%, using 524 
census bait takes and track scores respectively. 525 
It is generally considered that effective anticoagulants should control a rat infestation that is 526 
susceptible to it within about 35 days (EC, 2011).  The treatment at site six continued for a week 527 
longer than this but it is probable that the treatment would have ended earlier had burrow baiting 528 




Figure 1. Summary of the progression of six anticoagulant field trials conducted at farmsteads in 531 
Berkshire and Hampshire, UK.  Sites 1 and 2, 50 ppm difenacoum commercial pellet bait; sites 3 and 532 
4, 50 ppm bromadiolone commercial pellet bait; site 5, 23 ppm brodifacoum experimental wax block 533 
formulation; site 6, 23 ppm commercial brodifacoum pellet bait.  Hatched bars, census bait takes; 534 
open bars, poisoned bait takes; line, tracking score.  Note: track scores are for a 24-hour period 535 
during the pre- and post-treatment census, during the poisoned baiting they are aggregate scores 536 
for two- to three-day periods.  A six-day census period was employed at site 1 because of the initial 537 
reluctance of rats to take census bait.  The post-treatment lag period was prolonged at sites 2 and 4 538 
because of heavy snowfall. 539 
4. DISCUSSION 540 
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The application of anticoagulant rodenticides is the principle management intervention applied in 541 
almost all rodent pest scenarios worldwide, in both crop protection and public health (Jacob and 542 
Buckle, 2018).  No alternatives exist that are sufficiently effective (ECHA, 2017b) and possess similar 543 
safety features, including a specific antidote (vitamin K1) and a slow mode of action which provides 544 
time for its administration (Buckle and Eason, 2015).  There is little evidence of technology capable 545 
of fully replacing anticoagulants becoming available in the foreseeable future (Buckle and Smith, 546 
2015).  However, anticoagulant resistance is a significant threat to the continued effective use of 547 
these active substances (Berny et al., 2018 )and resistance management strategies are required to 548 
extend the useful lives of these essential products (RRAC, 2020). 549 
Research in the Hampshire and Berkshire area, over many years and using different resistance 550 
monitoring techniques, has shown the prevalent nature of the L120Q resistance SNP in the area of 551 
this study (Buckle, 2013; Jones et al., 2019).  The interactive resistance maps provided by the 552 
Rodenticide Resistance Action Committee of CropLife International (available here: 553 
http://guide.rrac.info/mapas-de-resistencia/reino-unido/?L=3%27A), based on DNA testing 554 
conducted at the University of Reading, demonstrate the known scale and geographical scope of the 555 
resistance focus.  Therefore, it was unsurprising that the rats on six Hampshire/Berkshire farms were 556 
found to carry the L120Q SNP.  What was surprising, however, was the very high incidence of 557 
resistance; with only one susceptible animal found in a sample of 107 rats from the trial sites, and 558 
the high incidence of homozygosity (86.9%).  These results indicate prolonged selection pressure 559 
towards resistance exerted by the application, over a period of more than 30 years, of only partially-560 
effective rodenticides.  The late J.H. Greaves wrote, “the unabated use of anticoagulants to which 561 
resistance has developed will unremittingly cause resistance to these compounds to spread” 562 
(Greaves, 1994).  Apparently this lesson was not learned and the consequences for resistance of a 563 
regulatory policy that, effectively, enforced the prolonged use of resisted active substances, is 564 
apparent (Jones et al., 2019).  Also, the relatively high initial numbers of rats on the trial farms (Table 565 
6) were not unusual at this resistance focus, in spite of almost continual but ineffectual attempts to 566 
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control them with bromadiolone and difenacoum baits (Quy et al., 1995), and by other physical 567 
means such as trapping, dogs and shooting. 568 
It is also clear from the foregoing that none of the six field trials described here progressed in an 569 
entirely predicted manner.  Rats appeared to be unusually reluctant to take bait at one site.  This 570 
may have resulted in an underestimate of the initial size of the infestation during census baiting, in 571 
turn leading to an over-estimate of treatment efficacy.  However, poor poisoned bait uptake and its 572 
consequential detrimental effect on treatment efficacy would have exerted possible bias in the 573 
opposite direction.  Heavy snowfall caused the work of the post-treatment census to be unavoidably 574 
abandoned and resumed later at two trial sites.  There is a possibility that this prolonged, 575 
unscheduled lag period may have permitted some rats to repopulate the sites, but the extreme 576 
winter weather conditions, very low temperatures and deep-laying snow, would have militated 577 
against this to a considerable extent.  On another site the treatment was interrupted when it was 578 
found, almost at the end of the treatment, that non-target grey squirrels were entering bait boxes 579 
and taking poisoned bait.  The trial could have been terminated at that point because very few rats 580 
apparently remained.  However, it was decided to pause the work, remove the squirrels, and then 581 
continue in an attempt to extinguish the infestation.  This resulted in a necessarily prolonged trial.  582 
Finally, poor bait takes, probably due to the proximity of palatable alternative food, and justifiable 583 
reluctance on the part of the researchers to employ burrow baiting because of the difficulty this 584 
presented in quantifying bait takes, resulted in another prolonged treatment at site 6; although 585 
virtually complete control was eventually achieved. 586 
In spite of these experimental difficulties, a consistent pattern emerges from this study on the field 587 
efficacy of anticoagulants against Hampshire/Berkshire L120Q rats.  The four 50 ppm difenacoum 588 
and bromadiolone treatments were substantially ineffective and the two applications of baits 589 
carrying 23 ppm brodifacoum were both highly effective.  The current regulatory authorisation 590 
requirement for proof of efficacy of a rodenticide is 90% mortality in field trials (ECHA, 2017a), and it 591 
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is clear that all the difenacoum and bromadiolone treatments failed this criterion by wide margins.  592 
Previously, bromadiolone had performed consistently better than difenacoum against Norway rats 593 
in the Hampshire resistance focus (Greaves et al., 1982b) but this was not seen in the present study.  594 
The resistance factors calculated here, using blood-clotting response tests conducted in 2009-10, 595 
confirmed a shift towards a higher degree of resistance than those observed previously (Greaves and 596 
Cullen-Ayres, 1988).  However, if the advanced ‘Berkshire’ phenotype had entirely replaced the 597 
once-prevalent, and more susceptible, ‘Hampshire’ phenotype at all the trial sites, we might have 598 
expected both compounds to perform consistently poorly where they were applied.  This was not 599 
the case, as at one site where each substance was used they provided a similar, partial degree of 600 
control; difenacoum, 60.3-60.9% mortality on site 2 and bromadiolone 37.2-66.3% mortality on site 601 
3.  However, at the other sites where bromadiolone and difenacoum were used the outcomes were 602 
similar in their degree of complete failure to that seen for bromadiolone in a field trial conducted 603 
many years earlier (Quy et al., 1995).  It seems likely, therefore, that at some sites other factors, in 604 
addition to anticoagulant resistance, may have influenced the outcomes of treatments, possibly the 605 
unwillingness of the rat infestations to take the commercial baits (Cowan et al., 1995).  Whatever 606 
the causes of the variable effectiveness of the two less-potent anticoagulants, it is clearly apparent 607 
that they should not be recommended for Norway rat control where the L120Q resistance mutation 608 
is prevalent (RRAG, 2018). 609 
Evidence has been growing for the past thirty years of widespread contamination of UK wildlife with 610 
SGARs (Shore et al., 2015).  The list of exposed species is extensive and includes, among others, barn 611 
owl (Tyto alba), red kite (Milvus milvus), buzzard (Buteo buteo), kestrel (Falco tinnunculus), stoat 612 
(Mustela erminea), weasel (Mustela nivalis), polecat (Mustela putorius), fox (Vulpes vulpes) and 613 
hedgehog (Erinaceus europaeus).  One of the few positive notes to emerge from this, however, is 614 
that there is currently no evidence that any exposed species has declined as a result of this exposure 615 
(Smith and Shore, 2015).  Indeed, some of the most exposed populations of birds (i.e. red kite, barn 616 
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owl and buzzard) are rapidly increasing, both in numbers and in their geographical distribution 617 
across the UK (Harris et al., 2019). 618 
In simple terms, the risk of non-target effects of rodenticide applications is a function of the intrinsic 619 
toxicity of the active substance to exposed species, the quantity applied and the duration of its 620 
availability in the environment (Newton, 2018).  In turn, the quantities applied are influenced by 621 
concentration of the active substance in the bait, the application rates (determined by the product 622 
label) and the size and scope of the treated rodent infestation.  Actual impacts are affected by the 623 
degree of risk of any non-target species’ exposure and the effectiveness of the risk mitigation 624 
measures employed when using these substances (Buckle and Prescott, 2018; López-Perea and 625 
Mateo, 2018; Shore and Coerdassier, 2018).  Table 6 shows the quantities of active substance 626 
released to the environment during SGAR applications reported here.  These ranged from 0.10 g to 627 
2.96 g of active substance per treatment; one almost thirty times the other.  Unsurprisingly, the 628 
unsuccessful bromadiolone and difenacoum treatments resulted in much larger emissions than the 629 
more successful brodifacoum treatments.  This was because smaller quantities of brodifacoum baits 630 
were applied (i.e. pulsed baiting, see Buckle and Eason, 2015), the baits contained lower 631 
concentrations of the active substance (23 ppm instead of 50 ppm) and the duration of feeding on 632 
brodifacoum baits by the treated rat infestations was shorter (Fig. 1).  The most significant period of 633 
risk of secondary exposure of predators during anticoagulant treatments is likely to be during the 634 
‘latency period’; that is after consumption of bait by target animals and before their deaths (Buckle 635 
and Prescott, 2018).  During this time the animals remain active in the environment, continue to 636 
consume rodenticide and exhibit normal behaviour until, latterly, showing some reduced sensory 637 
and motor function, and abnormal behaviours, due to poisoning (Cox and Smith, 1992).  When a 638 
lethal dose of an anticoagulant is taken, this latency period may be quite short, usually only 3-5 days 639 
and rarely longer than ten (Buckle and Eason, 2015).  However, in the unsuccessful difenacoum and 640 
bromadiolone treatments recorded here, the latency period is very much longer, in effect the entire 641 
remaining natural life of surviving rodents (Atterby et al., 2005) because of the long biological half-642 
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lives of these substances (Horak et al., 2018).  A scenario therefore emerges in this part of the UK 643 
where the L120Q SNP is widespread, and where difenacoum and bromadiolone continue to be used 644 
extensively, that a high proportion of individuals within extant Norway rat infestations carry SGAR 645 
residues that are virtually continuously available for ingestion by non-target animals through 646 
predation and scavenging.  This occurrence in Hampshire and Berkshire, and probably to a lesser 647 
extent in other resistance foci (Jones et al., 2019), may go some way to explain the widespread 648 
nature of anticoagulant residues in predatory birds and mammals, particularly of bromadiolone and 649 
difenacoum (Shore et al., 2019).  In the brodifacoum treatments, the relatively smaller quantities of 650 
active substance emitted resulted in the virtual extirpation of the rat infestations (Table 6) and, 651 
therefore, both to a lower overall SGAR emission and shorter duration of potential secondary 652 
exposure of predators. 653 
Important regulatory changes have been introduced recently in the UK concerning the permitted 654 
uses of the second-generation anticoagulants.  Firstly, as mentioned above, the more potent 655 
anticoagulants, brodifacoum, difethialone and flocoumafen, have been authorised for use outdoors.  656 
This has made available, for the first time, potentially highly-effective resistance-breaking active 657 
substances for use in resistance foci, such as that of Norway rat L120Q resistance studied here.  658 
However, to accompany this change, a programme of rodenticide stewardship has been introduced 659 
which has brought about important changes in whom can purchase SGARs and how they can be 660 
used (Buckle et al., 2017).  UK Government assessment of the stewardship regime will determine 661 
future rodenticide regulation and permitted use practices and, in so doing, will continue to affect the 662 
development and spread of anticoagulant resistance and the prevalence of anticoagulant residues in 663 
UK wildlife (GOG, 2019).   However, so far no significant increase in total SGAR residues has been 664 
detected in the chosen sentinel species, barn owl, as a result of the regulatory change which 665 
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Pellet (commercial) difenacoum 50 ppm 1 and 2 100-300 Twice weekly 
Pellet (commercial) bromadiolone 50 ppm 3 and 4 150-300 Twice weekly 
Wax block (20g) 
(experimental) 
brodifacoum 23 ppm 5 20-60 Three times 
weekly 
Pellet (commercial) brodifacoum 23 ppm 6 50 Three times 
weekly 
Table 1.  Rodenticide baits used, the concentrations of the active substance, application rates and 
the frequency of bait replenishment in the six field trials. 
  
Table(s)
Site Dates of trial Active substance No. tracking 
patches 




1 13.02.2009-08.05.2009 difenacoum 45 58 57 
2 26.10.2009-24.01.2010 difenacoum 39 82 90 
3 13.02.2009-21.04.2009 bromadiolone 54 78 77 
4 26.10.2009-24.01.2010 bromadiolone 46 94 97 
5 18.04.2016-29.07.2016 brodifacoum 35 50 55 
6 05.05.2016-23.12.2016 brodifacoum 32 50 90* 
Note: * 41 rat burrows were also baited for a 13-day period. 












1 bromadiolone Female (n=10) 5.00 mg.kg-1 
(8xED50) 
70.0 
Male (n=7) 1.41 mg.kg-1 
(3xED50) 
71.0 
difenacoum Female (n=9) 4.74 mg.kg-1 
(6xED50) 
44.4 





















3 bromadiolone Female (n=5) 5.00 mg.kg-1 
(8xED50) 
40.0 
Male (n=8) 1.41 mg.kg-1 
(3xED50) 
100.0 
difenacoum Female (n=1) 4.74 mg.kg-1 
(6xED50) 
100.0 
4 bromadiolone Female (n=6) 5.00 mg.kg-1 
(8xED50) 
33.3 
Male (n=2) 1.41 mg.kg-1 
(3xED50) 
50.0 
difenacoum Female (n=11) 4.74 mg.kg-1 
(6xED50) 
63.3 
Male (n=13) 1.95 mg.kg-1 
(3xED50) 
53.4 
Table 3.  The results of the blood clotting response tests conducted on rats from four of the six 
treated farms.  Doses administered are shown as both absolute values and as multiples of the ED50 
for fully susceptible animals. Dates of the trials are given in Table 2. 
  
 




Heterozygous Homozygous Sequencing 
failed 
% resistant 
1 32 0 1 30 1 100.0 
2 27 0 3 24 0 100.0 
3 13 0 1 12 0 100.0 
4 20 0 2 18 0 100.0 
5 9 1 1 5 2 85.7 
6 10 0 5 4 1 100.0 
totals 111 1 13 93 4  
Table 4.  Results of DNA sequencing for the L120Q resistance mutation among rats taken from the 




































1* 6.87 2.20 242 55 7.89 1.86 286 58 
2 33.36 10.57 418 115 13.20 4.20 169 45 
3 9.20 2.73 154 43 2.83 0.92 94 27 
4 15.07 5.49 285 84 17.80 5.57 323 87 
5 4.88 1.37 172 50 0.02 0.01 0 0 
6 9.78 3.18 336 96 0.05 0.03 4 3 
Note: * pre- and post-treatment census periods of six days at site 1. 


























1 difenacoum (50ppm) 2.20 (110) 28.57 1.43 15.5 +5.5 
2 difenacoum (50ppm) 10.57 (529) 59.24 2.96 60.3 60.9 
3 bromadiolone (50 ppm) 2.73 (136) 17.67 0.88 66.3 37.2 
4 bromadiolone (50 ppm) 5.49 (275) 43.19 2.16 +1.5 +3.6 
5 brodifacoum (23 ppm) 1.37 (69) 4.38 0.10 99.3 100.0 
6 brodifacoum (23 ppm) 3.18 (159) 9.68† 0.22 98.4 96.9 
Notes: 
§
 values in brackets are the estimated numbers of rats present at the start of the treatments 
(assumptions are given in the text) 
 * mortality estimates preceded by + indicate estimated population growth during treatment 
 † includes burrow bait that was applied but some of which was probably not consumed 
Table 6. The results of efficacy assessments conducted at the six trial sites.  The maximum daily pre-
treatment census bait take is shown as an indirect measure of the sizes of the initial infestations. 
 
Figure(s)
Click here to download high resolution image
Highlights 
 Field trials were conducted with three anticoagulants in Hampshire/Berkshire UK 
 Six farm sites were used where 87% of Norway rats were L120Q homozygous resistant 
 Bromadiolone and difenacoum were ineffective and should not be used against L120Q 
 Brodifacoum was fully effective, with lower anticoagulant environmental emissions 
 Rodenticide stewardship is in place, with resistance and environmental monitoring 
*Highlights (for review)
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